Ionis Pharmaceuticals Inc
F:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
Cohort PLC
LSE:CHRT
|
UK |
|
S
|
Shangri-La Hotel PCL
SET:SHANG
|
TH |
|
Vera Bradley Inc
F:ELI
|
US |
|
E
|
Eli Lilly and Co
SIX:LLY
|
US |
|
Centrale del Latte d'Italia SpA
MIL:CLI
|
IT |
|
Vimian Group AB
OTC:VIMGF
|
SE |
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
IL |
|
A
|
Aura Investments Ltd
TASE:AURA
|
IL |
|
Companhia Energetica do Rio Grande do Norte Cosern
BOVESPA:CSRN3
|
BR |
|
Nfl Biosciences SAS
PAR:ALNFL
|
FR |
|
IDFC Ltd
NSE:IDFC
|
IN |
|
Pattern SpA
MIL:PTR
|
IT |
|
B
|
Bangkok Chain Hospital PCL
SET:BCH
|
TH |
|
Fuji Oil Co Ltd
F:ACK
|
JP |
|
C
|
CID HoldCo Inc
NASDAQ:DAIC
|
US |
|
Two Harbors Investment Corp
F:2H2
|
US |
|
J
|
Joint Stock Commercial Bank for Investment and Development of Vietnam
VN:BID
|
VN |
Bankruptcy Probability
Ionis Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ionis Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
9.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ionis Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ionis Pharmaceuticals Inc has total debt of 1.9B USD. This includes both short-term (0 USD) and long-term (1.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
